78 related articles for article (PubMed ID: 15239124)
21. Targeting CXCR4 and FAK reverses doxorubicin resistance and suppresses invasion in non-small cell lung carcinoma.
Dragoj M; Milosevic Z; Bankovic J; Tanic N; Pesic M; Stankovic T
Cell Oncol (Dordr); 2017 Feb; 40(1):47-62. PubMed ID: 27822706
[TBL] [Abstract][Full Text] [Related]
22. Tumor-associated macrophages: the double-edged sword in cancer progression.
Chen JJ; Lin YC; Yao PL; Yuan A; Chen HY; Shun CT; Tsai MF; Chen CH; Yang PC
J Clin Oncol; 2005 Feb; 23(5):953-64. PubMed ID: 15598976
[TBL] [Abstract][Full Text] [Related]
23. Olfactomedin III expression contributes to anoikis-resistance in clonal variants of a human lung squamous carcinoma cell line.
Keenan J; Joyce H; Aherne S; O'Dea S; Doolan P; Lynch V; Clynes M
Exp Cell Res; 2012 Mar; 318(5):593-602. PubMed ID: 22281030
[TBL] [Abstract][Full Text] [Related]
24. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
Iwasaki I; Sugiyama H; Kanazawa S; Hemmi H
Cancer Chemother Pharmacol; 2002 Jun; 49(6):438-44. PubMed ID: 12107547
[TBL] [Abstract][Full Text] [Related]
25. Gallic acid inhibits the migration and invasion of A375.S2 human melanoma cells through the inhibition of matrix metalloproteinase-2 and Ras.
Lo C; Lai TY; Yang JS; Yang JH; Ma YS; Weng SW; Lin HY; Chen HY; Lin JG; Chung JG
Melanoma Res; 2011 Aug; 21(4):267-73. PubMed ID: 21734530
[TBL] [Abstract][Full Text] [Related]
26. [Effect of cisplatin on the expression of Pokemon gene: experiment with different human lung cancer cells].
Zhao ZH; Wang SF; Yu L; Wang J; Cong DG; Chang H; Wang XF; Zhang TW; Zhang J; Fu K; Jiang JY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1211-3. PubMed ID: 18844119
[TBL] [Abstract][Full Text] [Related]
27. Cross-resistance to diverse drugs is associated with primary cisplatin resistance in ovarian cancer cell lines.
Hamaguchi K; Godwin AK; Yakushiji M; O'Dwyer PJ; Ozols RF; Hamilton TC
Cancer Res; 1993 Nov; 53(21):5225-32. PubMed ID: 8106143
[TBL] [Abstract][Full Text] [Related]
28. miR‑133a suppresses cell proliferation, migration and invasion in human lung cancer by targeting MMP‑14.
Xu M; Wang YZ
Oncol Rep; 2013 Sep; 30(3):1398-404. PubMed ID: 23783274
[TBL] [Abstract][Full Text] [Related]
29. Carbon-ion beam irradiation effectively suppresses migration and invasion of human non-small-cell lung cancer cells.
Akino Y; Teshima T; Kihara A; Kodera-Suzumoto Y; Inaoka M; Higashiyama S; Furusawa Y; Matsuura N
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):475-81. PubMed ID: 19735871
[TBL] [Abstract][Full Text] [Related]
30. Cisplatin-dependent upregulation of death receptors 4 and 5 augments induction of apoptosis by TNF-related apoptosis-inducing ligand against esophageal squamous cell carcinoma.
Kondo K; Yamasaki S; Sugie T; Teratani N; Kan T; Imamura M; Shimada Y
Int J Cancer; 2006 Jan; 118(1):230-42. PubMed ID: 16003725
[TBL] [Abstract][Full Text] [Related]
31. Cross-resistance and glutathione-S-transferase-pi levels among four human melanoma cell lines selected for alkylating agent resistance.
Wang YY; Teicher BA; Shea TC; Holden SA; Rosbe KW; al-Achi A; Henner WD
Cancer Res; 1989 Nov; 49(22):6185-92. PubMed ID: 2804968
[TBL] [Abstract][Full Text] [Related]
32. Alkylating agents: in vitro studies of cross-resistance patterns in human cell lines.
Teicher BA; Cucchi CA; Lee JB; Flatow JL; Rosowsky A; Frei E
Cancer Res; 1986 Sep; 46(9):4379-83. PubMed ID: 3731096
[TBL] [Abstract][Full Text] [Related]
33. Chemoresistance induces enhanced adhesion and transendothelial penetration of neuroblastoma cells by down-regulating NCAM surface expression.
Blaheta RA; Daher FH; Michaelis M; Hasenberg C; Weich EM; Jonas D; Kotchetkov R; Doerr HW; Cinatl J
BMC Cancer; 2006 Dec; 6():294. PubMed ID: 17181871
[TBL] [Abstract][Full Text] [Related]
34. Reduced XPC messenger RNA level may predict a poor outcome of patients with nonsmall cell lung cancer.
Wu YH; Cheng YW; Chang JT; Wu TC; Chen CY; Lee H
Cancer; 2007 Jul; 110(1):215-23. PubMed ID: 17508409
[TBL] [Abstract][Full Text] [Related]
35. Characterization of non-small-cell lung cancer cell lines established before and after chemotherapy.
Kawai H; Kiura K; Tabata M; Yoshino T; Takata I; Hiraki A; Chikamori K; Ueoka H; Tanimoto M; Harada M
Lung Cancer; 2002 Mar; 35(3):305-14. PubMed ID: 11844606
[TBL] [Abstract][Full Text] [Related]
36. Enhanced invasiveness of drug-resistant acute myeloid leukemia cells through increased expression of matrix metalloproteinase-2.
Song JH; Kim SH; Cho D; Lee IK; Kim HJ; Kim TS
Int J Cancer; 2009 Sep; 125(5):1074-81. PubMed ID: 19449375
[TBL] [Abstract][Full Text] [Related]
37. Reduction of transglutaminase 2 expression is associated with an induction of drug sensitivity in the PC-14 human lung cancer cell line.
Han JA; Park SC
J Cancer Res Clin Oncol; 1999; 125(2):89-95. PubMed ID: 10190315
[TBL] [Abstract][Full Text] [Related]
38. Identification of a transcriptional profile associated with in vitro invasion in non-small cell lung cancer cell lines.
Lader AS; Ramoni MF; Zetter BR; Kohane IS; Kwiatkowski DJ
Cancer Biol Ther; 2004 Jul; 3(7):624-31. PubMed ID: 15153803
[TBL] [Abstract][Full Text] [Related]
39. Selection with melphalan or paclitaxel (Taxol) yields variants with different patterns of multidrug resistance, integrin expression and in vitro invasiveness.
Liang Y; Meleady P; Cleary I; McDonnell S; Connolly L; Clynes M
Eur J Cancer; 2001 May; 37(8):1041-52. PubMed ID: 11334731
[TBL] [Abstract][Full Text] [Related]
40. Doxorubicin-resistant, MRP1-expressing U-1285 cells are sensitive to idarubicin.
Jönsson-Videsäter K; Andersson G; Bergh J; Paul C
Ther Drug Monit; 2003 Jun; 25(3):331-9. PubMed ID: 12766562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
